Tag: Luis Mora
PharmaMar lung cancer drug lurbinectedin gets FDA orphan drug designation
Spanish pharma company PharmaMar’s lurbinectedin has secured orphan drug designation from the US Food and Drug Administration (FDA) for the treatment of small cell lung ... Read More